Biolase Technology, Inc. (BLTI) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts BLTI Hot Sheet
Price: $2.42 +2.54%
Financial Fact:
Sales and marketing: 4.26M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Sales and marketing: 4.26M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Biolase Technology, Inc. (NASDAQ: BLTI) reported Q2 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $12.08 million versus the consensus estimate of $12.01 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
